openPR Logo
Press release

Renal Denervation Market Generate High Returns throughout the Forecast Period Due To Increased Product Approvals

02-06-2019 10:43 AM CET | Health & Medicine

Press release from: Allied Market Research

Renal Denervation Market

Renal Denervation Market

The Renewable Energy Market is expected to reach $ 3,133 million by 2022, with an average annual growth rate of 48.5% over the forecast period of 2014-2022. The Symplicity Renal Denervation System is estimated to continue to generate high returns throughout the forecast period due to increased product approvals.

Europe has taken a leading position in the global market in 2015 and is expected to remain at the forefront in the future.

Compared to multidisciplinary therapies, increased hypertension and blood pressure, changes in people's lifestyles, improved healthcare infrastructure in developing countries, and increased cost effectiveness of renal hair loss procedures promote market growth. However, patient inconvenience and suffering during strict approval procedures and procedures for kidney removal devices hinders market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/522

Key players have adopted product development as their key strategy to cater to the changing needs of the industry.

Major players operating in this market include
• Ablative Solutions Inc.
• Boston Scientific Corporation
• Cardiosonic Ltd
• Kona Medical Inc.
• Medtronic plc
• Mercator MedSystems Inc.
• ReCor Medical Inc.
• Renal Dynamics Limited
• St. Jude Medical Inc.
• Terumo Medical Corporation.

As of 2015, Medtronic dominated the overall renal denervation market, followed by St. Jude Medical.

Vessix Renal Denervation System is projected to be the fastest growing segment, with a CAGR of 57.6% from 2016 to 2022, as this system can be used for arteries of variable diameter (has a balloon that can be expanded into variable sizes). In addition, it uses a full-color graphic user interface that increases the accuracy and operation of the device. Boston Scientific, manufacturer of Vessix Renal Denervation System, considers this market to be a potential growth opportunity for expanding its business.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/522

Radiofrequency was the most frequently used technology in the renal denervation market. In addition, it was the major segment in 2015 and is expected to lead throughout the forecast period. Ultrasound is projected to grow at the highest CAGR of 56.4%, as it overcomes the limitations of radiofrequency devices.

Key findings of Renal Denervation Market:
• On the basis of product type, the Symplicity Renal Denervation System segment accounted for the largest share, while Vessix Renal Denervation System is projected to grow at the fastest rate.
• Radiofrequency segment dominated the overall renal denervation market.
• Utrasound is poised to grow at the highest CAGR of 56.4% during the analysis period.
• Europe was the leading geographic market in 2015, and it is projected to lead for the next few years.
• Asia-Pacific is projected to grow at the highest CAGR of 50.6%.

Europes high share is attributed to the early start of this technology in European countries. In addition, most of the devices in this market have received a CE mark approval and are available for sales in the European region. On the other hand, North America accounts for a small proportion as renal denervation systems have not been approved by the FDA and are available only for investigational purpose in the North American market.

Asia-Pacific is expected to grow at the fastest rate during the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of hypertension, increase in awareness about the use of advanced technologies such as renal denervation systems, and high prevalence rate of resistant hypertension.

Access Full Summery @ https://www.alliedmarketresearch.com/renal-denervation-devices-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Denervation Market Generate High Returns throughout the Forecast Period Due To Increased Product Approvals here

News-ID: 1564399 • Views: 268

More Releases from Allied Market Research

Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 …
According to a new report published by Allied Market Research, titled, “Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market by Product, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global Diphtheria, Tetanus, and Pertussis Vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% from 2020-2027. The DTaP segment accounted for major
Burn Care Market Expected to Reach $3,134 Million by 2027
According to a new report published by Allied Market Research, titled, “Burn care Market by Product, Depth of Burn, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global burn care market size was valued at $1,992 million in 2019, and is projected to reach $3,134 million by 2027, growing at a CAGR of 5.6% from 2020 to 2027. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4395 Burns are injuries
Drug Delivery Devices Market projected to Cross $26.7 Billion by 2026
Drug Delivery Devices Market size was valued at $19 billion in 2018, and is expected to reach $26.7 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026. Drugs are used to improve health and to extend lives. However, the medications can be taken in various ways, including by swallowing, by absorption, by inhalation, through the skin, and by intravenous injection. For this, the drug delivery devices are developed,
Pharmaceutical Filtration Market on Position to Hit $7.74 Billion by 2026
Pharmaceutical filtration is defined as a filtration process to separate suspended particles from a medium or solution by passing them through a membrane. They reduce or eliminate the bacteria or other microorganisms in process components. The filtration process can be combined with other pharmaceutical manufacturing operations. Pharmaceutical filters are used in the production of small molecule ingredients such as active pharmaceutical ingredients (APIs) and pharmaceutical excipients. In addition, it is

All 5 Releases


More Releases for Renal

Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Insufficiency Market Vendor Growth Landscape 2025
Global Renal Insufficiency Market: Snapshot The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support. However, the participants of the global renal insufficiency market must take a note of weak competition among the marketed products for the
Acute Renal Failure - Pipeline Review, H1 2018
"The Report Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Acute Renal Failure Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)
Renal Diseases Pharmaceutical and Healthcare Analysis Information
Pune, India, 9th November 2017: WiseGuyReports announced addition of new report, titled “Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for”. Summary The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Cluster Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Renal Cluster Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Kidney Fibrosis, Chronic Kidney Disease (Chronic Renal Failure), Acute Renal Failure (ARF), Kidney Transplant Rejection, and